The Use of Thermal Suits as Preventing Hypothermia During Surgery
1 other identifier
interventional
100
1 country
1
Brief Summary
Unintentional hypothermia of a patient is a common adverse effect during surgical procedures. The aim of this prospective, randomised, controlled study is to determine whether the use of thermal suit could prevent surgical patient from experiencing thermal loss than conventional measures. Hypothesis: The investigators assume that a difference of 0.5°C in body temperature between the groups is clinically relevant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4 prostate-cancer
Started Nov 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2012
CompletedFirst Posted
Study publicly available on registry
April 5, 2012
CompletedStudy Start
First participant enrolled
November 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedJanuary 4, 2017
January 1, 2017
5 months
March 29, 2012
January 3, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Temperature
from one hour before surgery up to the ward after surgery, estimated 10 hours
Study Arms (2)
Thermal suit
EXPERIMENTALRandomly selected half of the patients will use thermal suit prior to anesthesia, during the surgery and post anesthesia care unit.
Conventional clothing
ACTIVE COMPARATORRandomly selected half of the patients will use conventional clothing prior to anesthesia, during the surgery and post anesthesia care unit.
Interventions
Eligibility Criteria
You may qualify if:
- radical prostatectomy, American Society of Anaesthesiologists class I-III, age 18-90
You may not qualify if:
- mental status with inability to give informed consent, neuromuscular disorders, Raynaud's disease, unstable angina pectoris
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tampere University Hospital
Tampere, 33521, Finland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sirkka-Liisa Lauronen, MD
Tampere University Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2012
First Posted
April 5, 2012
Study Start
November 1, 2012
Primary Completion
April 1, 2013
Study Completion
November 1, 2014
Last Updated
January 4, 2017
Record last verified: 2017-01